Cargando…
An Intensified Regimen Containing Linezolid Could Improve Treatment Response in Mycobacterium abscessus Lung Disease
BACKGROUND: Treatment response for the Mycobacterium abscessus (M. abscessus) lung disease remains far from satisfying. An effective regimen is needed to solve the problem. METHODS: We retrospectively reviewed the medical records of all patients with M. abscessus lung disease who received antibiotic...
Autores principales: | Li, Hua, Tong, Li, Wang, Jun, Liang, Qingtao, Zhang, Yun, Chu, Naihui, Chen, Xiaoyou, Duan, Hongfei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885786/ https://www.ncbi.nlm.nih.gov/pubmed/31828137 http://dx.doi.org/10.1155/2019/8631563 |
Ejemplares similares
-
Characterization of In Vitro Resistance to Linezolid in Mycobacterium abscessus
por: Negatu, Dereje A., et al.
Publicado: (2023) -
Molecular Analysis of Linezolid-Resistant Clinical Isolates of Mycobacterium abscessus
por: Ye, Meiping, et al.
Publicado: (2019) -
Clinical Utility of Contezolid-Containing Regimens in 25 Cases of Linezolid-Intolerable Tuberculosis Patients
por: Wang, Jun, et al.
Publicado: (2023) -
Mycobacterium abscessus Associated Peritonitis with CAPD Successfully Treated Using a Linezolid and Tedizolid Containing Regimen Suggested Immunomodulatory Effects
por: Seki, Masafumi, et al.
Publicado: (2020) -
Antibacterial activity of the novel oxazolidinone contezolid (MRX-I) against Mycobacterium abscessus
por: Gao, Shan., et al.
Publicado: (2023)